Bandingkan Harga & Kinerja Multi Medika Internasional Tbk. (MMIX) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multi Medika Internasional Tbk. dan Organon Pharma Indonesia Tbk.: Multi Medika Internasional Tbk. diperdagangkan di Rp850 (kapitalisasi pasar 4,01 T, volume 24 jam 54,76 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multi Medika Internasional Tbk. jauh lebih besar — sekitar 38,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MMIX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,01 T | 104,4 M |
Volume | 54,76 jt | — |
Lot | 547,61 rb | — |
Perputaran | 45,99 M | — |
Harga Rata-rata | 839,86 | — |
Nilai Transaksi | 45,99 M | — |
Harga Ekuilibrium Indikatif | 850 | — |
Volume Ekuilibrium Indikatif | 3,37 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multi Medika Internasional Tbk.
PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Selengkapnya di halaman MMIX →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
